![William John Robinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William John Robinson
Directeur/Bestuurslid bij Cycle Pharmaceuticals Ltd.
Actieve functies van William John Robinson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cycle Pharmaceuticals Ltd.
![]() Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Directeur/Bestuurslid | 01-11-2013 | - |
Loopbaan van William John Robinson
Eerdere bekende functies van William John Robinson
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PLETHORA SOLUTIONS HOLDINGS PLC | Directeur/Bestuurslid | 01-03-2007 | 01-07-2013 |
Voorzitter | 26-06-2009 | 12-04-2013 | |
Shionogi Pharma, Inc.
![]() Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Directeur/Bestuurslid | 01-01-2004 | 09-10-2008 |
ELI LILLY AND COMPANY | Verkoop & Marketing | 01-01-1976 | 01-01-2004 |
UCB Celltech
![]() UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Corporate Officer/Principal | 01-01-2005 | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 3 |
Chairman | 1 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 6 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Shionogi Pharma, Inc.
![]() Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Health Technology |
Plethora Solutions Holdings Plc
![]() Plethora Solutions Holdings Plc Pharmaceuticals: MajorHealth Technology Plethora Solutions Holdings Plc operates as a pharmaceutical company. It engages in the development and marketing of products for the treatment and management of urological disorders. The firm operates through the Plethora Development and The Urology Co. segments. The Plethora Development segment develops new pharmaceutical products. The Urology Co. segment sells and markets pharmaceutical and healthcare products. The company was founded by Michael Grant Wyllie and Neil Brent Stafford in December 2003 and is headquartered in Chalgrove, the United Kingdom. | Health Technology |
UCB Celltech
![]() UCB Celltech BiotechnologyHealth Technology Part of UCB SA, UCB Celltech is a British company that develops novel therapeutic products for humans. The company is based in Slough, UK and was founded in 2006. | Health Technology |
Cycle Pharmaceuticals Ltd.
![]() Cycle Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Cycle Pharmaceuticals Ltd. is a privately-owned biotechnology company headquartered in Cambridge, UK. The British company focuses on rare metabolic, immunological, and neurological genetic conditions, including multiple sclerosis. Cycle Pharmaceuticals utilizes the latest pharmaceutical technologies to provide superior drug treatments and individualized patient support services. Cycle Pharmaceuticals Ltd. was founded in 2012 with the aim of delivering drug treatments and services to the under-served rare disease patient community. James Alexander Harrison has been the CEO of the company since 2012. | Health Technology |